1. An TQ, Peng JM, Tian ZJ, Zhao HY, Li N, Liu YM, Chen JZ, Leng CL, Sun Y, Chang D, Tong GZ. Pseudorabies virus variant in Bartha-K61-vaccinated pigs, China, 2012. Emerg Infect Dis. 2013; 19:1749–1755.
Article
2. Eloit M, Fargeaud D, L'Haridon R, Toma B. Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies. Arch Virol. 1988; 99:45–56.
Article
3. Ficińska J, Bieńkowska-Szewczyk K, Jacobs L, Płucienniczak G, Płucienniczak A, Szewczyk B. Characterization of changes in the short unique segment of pseudorabies virus BUK-TK900 (Suivac A) vaccine strain. Arch Virol. 2003; 148:1593–1612.
Article
4. Kimman TG, de Wind N, Oei-Lie N, Pol JMA, Berns AJM, Gielkens ALJ. Contribution of single genes within the unique short region of Aujeszk's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. J Gen Virol. 1992; 73:243–251.
Article
5. Kit S, Kit M, Pirtle EC. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus. Am J Vet Res. 1985; 46:1359–1367.
6. Klupp BG, Hengartner CJ, Mettenleiter TC, Enquist LW. Complete, annotated sequence of the pseudorabies virus genome. J Virol. 2004; 78:424–440.
Article
7. Lomniczi B, Blankenship ML, Ben-Porat T. Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes. J Virol. 1984; 49:970–979.
Article
8. Lü S, Guo G, Wei F, Wang W, Dong B, Bi Y, Miao L, Shen Z. Study on safety and immune efficiency of pseudorabies virus alive vaccine with gE−/gI−2;/TK− gene deleted. Prog Vet Med. 2014; 35:1–5.
9. Luo Y, Li N, Cong X, Wang CH, Du M, Li L, Zhao B, Yuan J, Liu DD, Li S, Li Y, Sun Y, Qiu HJ. Pathogenicity and genomic characterization of a pseudorabies virus variant isolated from Bartha-K61-vaccinated swine population in China. Vet Microbiol. 2014; 174:107–115.
Article
10. Mettenleiter TC. Immunobiology of pseudorabies (Aujeszky's disease). Vet Immunol Immunopathol. 1996; 54:221–229.
Article
11. Mulder WAM, Jacobs L, Priem J, Kok GL, Wagenaar F, Kimman TG, Pol JMA. Glycoprotein gE-negative pseudorabies virus has a reduced capability to infect second- and third-order neurons of the olfactory and trigeminal routes in the porcine central nervous system. J Gen Virol. 1994; 75:3095–3106.
Article
12. Peng J, An T, Zhao H, Liu Y, Chen J, Leng C, Sun Y, Chang D, Tian Z, Tong G. Identification and antigenic variation of new epidemiology of pseudorabies virus from swine. Chin J Prev Vet Med. 2013; 35:1–4.
13. Peng J, Chen J, Tian Z, Wang Y, Zhou Y, An T, Tong G. Identification of the deletion in the Us region of pseudorabies virus Bartha K61 strain. Chin Vet Sci. 2008; 38:646–649.
14. Petrovskis EA, Timmins JG, Gierman TM, Post LE. Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63. J Virol. 1986; 60:1166–1169.
Article
15. Pomeranz LE, Reynolds AE, Hengartner CJ. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiol Mol Biol Rev. 2005; 69:462–500.
Article
16. Rauh I, Mettenleiter TC. Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol. 1991; 65:5348–5356.
Article
17. Wang CH, Yuan J, Qin HY, Luo Y, Cong X, Li Y, Chen J, Li S, Sun Y, Qiu HJ. A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China. Vaccine. 2014; 32:3379–3385.
Article
18. Wu R, Bai C, Sun J, Chang S, Zhang X. Emergence of virulent pseudorabies virus infection in northern China. J Vet Sci. 2013; 14:363–365.
Article
19. Yu X, Zhou Z, Hu D, Zhang Q, Han T, Li X, Gu X, Yuan L, Zhang S, Wang B, Qu P, Liu J, Zhai X, Tian K. Pathogenic pseudorabies virus, China, 2012. Emerg Infect Dis. 2014; 20:102–104.
Article
20. Yuan Q, Li Z, Nan X, Wu Y, Li Y. Isolation and identification of pseudorabies virus. Chin J Prev Vet Med. 1987; 3:10–11.